Adam Althaus
Papers
1
Total Citations
6
H-Index
1
About
Adam Althaus is a urologic surgeon and researcher whose work focuses on the intersection of surgical innovation and patient safety, particularly in the context of minimally invasive kidney surgery. His key research areas include robotic partial nephrectomy, perioperative management of antiplatelet therapy, and strategies to reduce hemorrhagic complications in urologic oncology. Althaus is best known for his landmark study, "Aspirin and clopidogrel during robotic partial nephrectomy, is it safe?" (2015, 6 citations), which challenged conventional surgical dogma by systematically evaluating the risks of continuing dual antiplatelet therapy during robotic kidney surgery. This work provided critical evidence that, in carefully selected patients, the benefits of preventing thrombotic events may outweigh the risks of bleeding, offering a safer pathway for those with cardiovascular comorbidities. Though his citation count is modest, his contribution has practical, high-impact implications for perioperative protocols. Althaus’s research exemplifies the careful balancing act between oncologic efficacy and medical comorbidity management, making him a thoughtful voice in the evolving field of robotic urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1Aspirin and clopidogrel during robotic partial nephrectomy, is it safe?6 citations · 2015